Astellas enters smart phone app arena
Astellas Pharma has released the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application for smart phones; designed to give physicians access to published criteria used to assess the need for a patient to have cardiac radionuclide imaging (RNI).
The application is currently available for free download on the iPhone, BlackBerry and Android platforms.
The AUC for RNI describes 67 individual patient indications, eight indication categories and five algorithms, according to the Deerfield, Ill.-based Astellas.
According to the company, the app guides physicians step-by-step through the criteria to evaluate patient history, clinical factors and other important information to receive an instant appropriate use score for RNI. By entering information, physicians will receive a rating on a scale of 1-9 suggesting if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3) for RNI. Ratings can be viewed either by indication/category or patient algorithm, the company reported.
The application is currently available for free download on the iPhone, BlackBerry and Android platforms.
The AUC for RNI describes 67 individual patient indications, eight indication categories and five algorithms, according to the Deerfield, Ill.-based Astellas.
According to the company, the app guides physicians step-by-step through the criteria to evaluate patient history, clinical factors and other important information to receive an instant appropriate use score for RNI. By entering information, physicians will receive a rating on a scale of 1-9 suggesting if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3) for RNI. Ratings can be viewed either by indication/category or patient algorithm, the company reported.